Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What are 10K annual reports?

10K reports are comprehensive annual reports filed by public companies with the SEC, containing detailed financial statements, business operations, risk factors, and management discussion.

How often are annual reports updated?

Annual reports are typically filed once per year, usually within 60-90 days after the company's fiscal year end. We update our database as soon as new reports become available.

How do I analyze CNS stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CNS investment potential.

What is CNS stock price today?

Get real-time CNS stock price, historical data, and price charts on Financhill. Track CNS performance with our advanced analysis tools.

Is CNS a good investment?

Evaluate CNS investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

How to buy CNS stock?

To buy CNS stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CNS?

View detailed market capitalization data and company valuation metrics for CNS on our comprehensive analysis page.

What is the P/E ratio of CNS?

Use our fundamental analysis tools to view CNS P/E ratio and compare valuation metrics with industry peers.

What are CNS earnings?

View CNS earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Back

Cohen & Steers, Inc. (New York) 10K Form

Sell

CNS
Cohen & Steers, Inc. (New York)

Last Price:

$62.57

Seasonality Move:

5.75%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2020-08-07	10Q	CNS/Cohen & Steers, Inc. (New York) Quarterly
2020-05-08	10Q	CNS/Cohen & Steers, Inc. (New York) Quarterly
2020-02-28	10K	CNS/Cohen & Steers, Inc. (New York) Annual
2019-11-12	10Q	CNS/Cohen & Steers, Inc. (New York) Quarterly
2019-08-06	10Q	CNS/Cohen & Steers, Inc. (New York) Quarterly
2019-05-09	10Q	CNS/Cohen & Steers, Inc. (New York) Quarterly

Receive CNS News And Ratings

See the #1 stock for the next 7 days that we like better than CNS

CNS Financial Statistics

Sales & Book Value

Annual Sales:	$571.5M
Cash Flow:	$55.7M
Price / Cash Flow:	16.88
Annual Sales:	$11.01
Price / Book:	5.77

Profitability

EPS (TTM):	2.97370
Net Income (TTM):	$157.4M
Gross Margin:	$488.8M
Return on Equity:	26.48%
Return on Assets:	18.99%

Cohen & Steers, Inc. (New York) Earnings Forecast

Key Cohen & Steers, Inc. (New York) Financial Ratios

The Gross Profit Margin over the past 26 years for CNS is 85.53%.
The Selling, General & Administrative Expenses for CNS have been equal to 0.00% of Gross Profit Margin.
The Interest Expense is 0.00% of Operating Income.
The Net Earning history of CNS is 27.54% of Total Revenues.
Per Share Earnings over the last 26 years have been positive in 15 years.

Cohen & Steers, Inc. (New York) Stock Price Chart

Industry, Sector and Symbol

Stock Exchange:	NYSE
Industry:	Capital Markets
Sector:	Financials
Current Symbol:	CNS
CUSIP:	19247A
Website:	cohenandsteers.com

Debt

Debt-to-Equity Ratio:	0.25
Current Ratio:	3.33
Quick Ratio:	1.23

Price-to-Earnings

Trailing P/E Ratio:	21.22
Forward P/E Ratio:	16.72

CNS Technical Analysis vs Fundamental Analysis